Dell stock rallies as analysts show love ahead of Q1 earnings
Dell Technologies (DELL) ripped higher on Friday as a series of analyst upgrades and price target hikes fuelled intense buying momentum ahead of
Gold
Gold
Take-Two stock falls as weak FY27 guidance offsets GTA VI hype
Shares of Take-Two Interactive Software (TTWO) fell on Friday despite the video game publisher reporting better-than-expected quarterly results and reaffirming the release timeline
Gold
Generac stock jumps 9%: Why is Jefferies bullish on the stock?
Shares of Generac Holdings (GNRC) surged on Friday after Jefferies upgraded the backup power equipment maker, citing growing momentum in AI-driven data center
Gold
Dow hits record high as easing yields lift Wall Street
Wall Street closed higher on Friday, with the Dow Jones Industrial Average reaching an intraday record high, as easing Treasury yields and optimism
Gold
Xi hosted Trump, then Putin, and showed where China’s leverage lies
In Beijing, the choreography said almost as much as the communiques. Air Force One had barely left Chinese airspace before Vladimir Putin’s plane
Gold
Iran’s control of Strait of Hormuz raises legal issues; reopening unlikely
Iran’s tightening grip on the Strait of Hormuz has left global energy markets and shipping in turmoil, with The Financial Times reporting that
Gold
These three stocks are must-own ahead of the SpaceX IPO
As the global financial community eagerly awaits SpaceX’s historic initial public offering (IPO) – rumoured to command some $1.7 trillion valuation on June
Gold
Fears and frenzy mount as SpaceX, OpenAI and Anthropic prepare for a $4T AI IPO wave
Silicon Valley is heading toward what could become one of the most consequential listing waves in modern market history, with artificial intelligence heavyweights
Oil
Commodity wrap: Oil gains as US–Iran talks stall; gold slips, copper resilient
Oil prices gained on the last day of the week as no breakthrough has been reached in the US-Iran peace negotiations, which is
Oil
Merck stock jumps as Keytruda combo trials boost cancer pipeline
Shares of Merck & Co. (MRK) rose 5% on Friday after the pharmaceutical giant reported positive developments across multiple oncology programs, reinforcing investor